Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026)
Family Office Of America's (FOFA) quarterly Liabilities and Shareholders Equity came in at $2.3 million in Q1 2026, up 296.35% year-on-year from $570468.0 in Q1 2025, and up 46.53% quarter-over-quarter from $1.5 million in Q4 2025.
Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Liabilities and Shareholders Equity across 6 years of filings, most recently posting $2.3 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $2.3 million, up 296.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (up 644.74% YoY), and the FY2025 annual result was $1.5 million, up 7397.41% from the prior year.
- Liabilities and Shareholders Equity came in at $2.3 million for Q1 2026 at Family Office Of America, up from $1.5 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 million in Q1 2026 to a low of $2431.0 in Q4 2023.
- The 5-year median for Liabilities and Shareholders Equity is $239812.0 (2022), against an average of $476445.1.
- Across the five-year window, Liabilities and Shareholders Equity slumped 99.18% in 2023 and surged 7397.41% in 2025, its largest moves.
- Family Office Of America's Liabilities and Shareholders Equity stood at $295461.0 in 2022, then plunged by 99.18% to $2431.0 in 2023, then surged by 746.61% to $20581.0 in 2024, then soared by 7397.41% to $1.5 million in 2025, then surged by 46.53% to $2.3 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.3 million (Q1 2026), $1.5 million (Q4 2025), and $829347.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Family Office Of America | - | - | 783,126.00 | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 829,347.00 |
| Jun 30, 2025 | 588,771.00 |
| Mar 31, 2025 | 570,468.00 |
| Dec 31, 2024 | 20,581.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 63,456.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 121,938.00 |
| Jun 30, 2023 | 149,510.00 |
| Mar 31, 2023 | 184,163.00 |
| Dec 31, 2022 | 295,461.00 |
| Sep 30, 2022 | 453,199.00 |
| Jun 30, 2022 | 402,437.00 |
| Dec 31, 2021 | 800,063.00 |